PDB Short entry for 1OGA HEADER IMMUNE SYSTEM/RECEPTOR 28-APR-03 1OGA TITLE A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR TITLE 2 RECOGNITION. COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR ALPHA-1, -2, -3, RESIDUES 25-300; COMPND 5 SYNONYM: MHC, A-2 ALPHA CHAIN PRECURSOR; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: BETA-2-MICROGLOBULIN, RESIDUES 21-119; COMPND 11 SYNONYM: HDCMA22P, B2M; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: GILGFVFTL; COMPND 15 CHAIN: C; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 4; COMPND 18 MOLECULE: T-CELL RECEPTOR ALPHA CHAIN V REGION; COMPND 19 CHAIN: D; COMPND 20 ENGINEERED: YES; COMPND 21 OTHER_DETAILS: CONTAINS ALSO C (CONSTANT) REGION; COMPND 22 MOL_ID: 5; COMPND 23 MOLECULE: T-CELL RECEPTOR BETA CHAIN C REGION; COMPND 24 CHAIN: E; COMPND 25 FRAGMENT: EXTRACELLULAR, RESIDUES 1-130; COMPND 26 SYNONYM: TRBC1; COMPND 27 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BLR; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PETT22B+; SOURCE 9 OTHER_DETAILS: REFOLDED FROM INCLUSION BODIES. REFOLDED FROM SOURCE 10 INCLUSION BODIES; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BLR; SOURCE 18 EXPRESSION_SYSTEM_VECTOR: PETT22B+; SOURCE 19 OTHER_DETAILS: REFOLDED FROM INCLUSION BODIES. REFOLDED FROM SOURCE 20 INCLUSION BODIES; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606; SOURCE 26 OTHER_DETAILS: REFOLDED FROM INCLUSION BODIES. PEPTIDE CHAIN SOURCE 27 C.REFOLDED FROM INCLUSION BODIES; SOURCE 28 MOL_ID: 4; SOURCE 29 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 30 ORGANISM_COMMON: HUMAN; SOURCE 31 ORGANISM_TAXID: 9606; SOURCE 32 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 33 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 34 EXPRESSION_SYSTEM_STRAIN: BLR; SOURCE 35 EXPRESSION_SYSTEM_VECTOR: PETT22B+; SOURCE 36 OTHER_DETAILS: REFOLDED FROM INCLUSION BODIES. REFOLDED FROM SOURCE 37 INCLUSION BODIES; SOURCE 38 MOL_ID: 5; SOURCE 39 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 40 ORGANISM_COMMON: HUMAN; SOURCE 41 ORGANISM_TAXID: 9606; SOURCE 42 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 43 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 44 EXPRESSION_SYSTEM_STRAIN: BLR; SOURCE 45 EXPRESSION_SYSTEM_VECTOR: PETT22B+; SOURCE 46 OTHER_DETAILS: REFOLDED FROM INCLUSION BODIES. REFOLDED FROM SOURCE 47 INCLUSION BODIES KEYWDS IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM-RECEPTOR-COMPLEX, TCR, MHC, KEYWDS 2 IMMUNODOMINANCE, FLU, COMPLEX, TRANSMEMBRANE, GLYCOPROTEIN, KEYWDS 3 POLYMORPHISM, T-CELL, RECEPTOR, IMMUNE SYSTEM-RECEPTOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.B.E.STEWART-JONES,A.J.MCMICHAEL,J.I.BELL,D.I.STUART,E.Y.JONES REVDAT 5 13-DEC-23 1OGA 1 REMARK REVDAT 4 24-FEB-09 1OGA 1 VERSN REVDAT 3 11-SEP-03 1OGA 1 JRNL REVDAT 2 11-JUL-03 1OGA 1 REMARK REVDAT 1 19-JUN-03 1OGA 0 JRNL AUTH G.B.E.STEWART-JONES,A.J.MCMICHAEL,J.I.BELL,D.I.STUART, JRNL AUTH 2 E.Y.JONES JRNL TITL A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T CELL RECEPTOR JRNL TITL 2 RECOGNITION JRNL REF NAT.IMMUNOL. V. 4 657 2003 JRNL REFN ISSN 1529-2908 JRNL PMID 12796775 JRNL DOI 10.1038/NI942 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 199296.380 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.0 REMARK 3 NUMBER OF REFLECTIONS : 187755 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 9329 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.002 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.45 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 77.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 14792 REMARK 3 BIN R VALUE (WORKING SET) : 0.3650 REMARK 3 BIN FREE R VALUE : 0.3710 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 783 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6624 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 568 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.78000 REMARK 3 B22 (A**2) : 2.54000 REMARK 3 B33 (A**2) : 2.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.19000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM SIGMAA (A) : 0.20 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.21 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.860 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.760 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.690 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.010 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.150 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 51.27 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESOLUTION-DEPENDENT WEIGHTING, BULK REMARK 3 SOLVENT MODEL USED REMARK 4 REMARK 4 1OGA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-APR-03. REMARK 100 THE DEPOSITION ID IS D_1290012590. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 200813 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 17.40 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 38.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.83000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: PDB ENTRY 1QSF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% PEG8000, 50MM MES PH 6.5, PH 6.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 54.41900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET D 2 REMARK 465 GLU D 203 REMARK 465 ASN D 204 REMARK 465 ASP D 205 REMARK 465 GLY D 206 REMARK 465 GLY D 207 REMARK 465 GLY D 208 REMARK 465 CYS D 209 REMARK 465 LYS D 210 REMARK 465 HIS D 211 REMARK 465 HIS D 212 REMARK 465 HIS D 213 REMARK 465 HIS D 214 REMARK 465 HIS D 215 REMARK 465 HIS D 216 REMARK 465 MET E 1 REMARK 465 VAL E 2 REMARK 465 ASP E 3 REMARK 465 GLY E 4 REMARK 465 ASP E 246 REMARK 465 ARG E 247 REMARK 465 GLY E 248 REMARK 465 GLY E 249 REMARK 465 GLY E 250 REMARK 465 CYS E 251 REMARK 465 ASP E 252 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PRO D 202 CA C O CB CG CD REMARK 470 GLN E 245 CA C O CB CG CD OE1 REMARK 470 GLN E 245 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ARG A 219 N GLY A 221 2.19 REMARK 500 SD MET E 34 O ALA E 94 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -128.89 52.59 REMARK 500 HIS A 114 102.09 -165.14 REMARK 500 ASP A 137 -162.44 -165.78 REMARK 500 SER A 195 -176.66 173.60 REMARK 500 HIS A 197 -2.76 -150.12 REMARK 500 PRO A 210 -178.82 -69.45 REMARK 500 ASP A 220 -48.42 53.90 REMARK 500 ASP A 223 138.12 -19.12 REMARK 500 ASP A 227 48.08 37.59 REMARK 500 TRP B 60 -3.81 77.00 REMARK 500 VAL D 51 -40.19 -130.93 REMARK 500 LYS D 60 -123.21 62.77 REMARK 500 ASP D 117 55.48 -145.71 REMARK 500 ASP D 130 -152.17 56.28 REMARK 500 LYS D 131 111.33 50.53 REMARK 500 LYS D 179 -179.08 -63.76 REMARK 500 PHE D 188 43.53 -107.34 REMARK 500 ASP D 196 40.71 -92.64 REMARK 500 ALA E 83 -83.97 -52.37 REMARK 500 GLN E 84 -171.27 -171.88 REMARK 500 LYS E 85 56.47 -69.19 REMARK 500 ASN E 86 26.90 -170.45 REMARK 500 ALA E 89 176.47 178.39 REMARK 500 SER E 100 -11.67 81.48 REMARK 500 GLN E 180 74.71 -157.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A1M RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDETYPDINQML FROM REMARK 900 GAG PROTEIN OF HIV2 REMARK 900 RELATED ID: 1A1N RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTYFROM THE REMARK 900 NEF PROTEIN (75- 82) OF HIV1 REMARK 900 RELATED ID: 1A1O RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) REMARK 900 FROM THE MALARIA PARASITE P. FALCIPARUM REMARK 900 RELATED ID: 1A6Z RELATED DB: PDB REMARK 900 HFE (HUMAN) HEMOCHROMATOSIS PROTEIN REMARK 900 RELATED ID: 1A9B RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 1A9E RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 1AGB RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION) REMARK 900 RELATED ID: 1AGC RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION) REMARK 900 RELATED ID: 1AGD RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE) REMARK 900 RELATED ID: 1AGE RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION) REMARK 900 RELATED ID: 1AGF RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION) REMARK 900 RELATED ID: 1AKJ RELATED DB: PDB REMARK 900 COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 ANDTHE T CELL REMARK 900 CORECEPTOR CD8 REMARK 900 RELATED ID: 1AO7 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA- REMARK 900 A 0201 REMARK 900 RELATED ID: 1B0G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HUMAN PEPTIDE P1049 REMARK 900 RELATED ID: 1B0R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED WITH A PEPTIDE WITH THE REMARK 900 CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP REMARK 900 RELATED ID: 1BD2 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND REMARK 900 MHC CLASS I MOLECULE HLA-A 0201 REMARK 900 RELATED ID: 1CE6 RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUSNUCLEOPROTEIN PEPTIDE REMARK 900 RELATED ID: 1DE4 RELATED DB: PDB REMARK 900 HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRINRECEPTOR REMARK 900 RELATED ID: 1DUY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX PEPTIDE COMPLEX REMARK 900 RELATED ID: 1DUZ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) INCOMPLEX REMARK 900 WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN REMARK 900 RELATED ID: 1E27 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM1 (LPPVVAKEI) REMARK 900 RELATED ID: 1E28 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM2 (TAFTIPSI) REMARK 900 RELATED ID: 1EFX RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL REMARK 900 RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3 REMARK 900 RELATED ID: 1EXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR REMARK 900 RELATED ID: 1GZP RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH GM2 GANGLIOSIDE REMARK 900 RELATED ID: 1GZQ RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL REMARK 900 RELATED ID: 1HHG RELATED DB: PDB REMARK 900 RELATED ID: 1HHH RELATED DB: PDB REMARK 900 RELATED ID: 1HHI RELATED DB: PDB REMARK 900 RELATED ID: 1HHJ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309- REMARK 900 317) REMARK 900 RELATED ID: 1HHK RELATED DB: PDB REMARK 900 RELATED ID: 1HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 ( HLA-A2, HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1HSA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA- B(ASTERISK)2705 REMARK 900 RELATED ID: 1HSB RELATED DB: PDB REMARK 900 CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 ( LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1I1F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1I1Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1I4F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4- PEPTIDE COMPLEX REMARK 900 RELATED ID: 1I7R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1058 REMARK 900 RELATED ID: 1I7T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-5V REMARK 900 RELATED ID: 1I7U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-6V REMARK 900 RELATED ID: 1IM3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2BOUND TO REMARK 900 THE MHC CLASS I MOLECULE HLA-A2/TAX REMARK 900 RELATED ID: 1IM9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELLINHIBITORY REMARK 900 RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 REMARK 900 RELATED ID: 1JF1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ADECAMERIC ALTERED REMARK 900 PEPTIDE LIGAND FROM THE MART-1/MELAN-A REMARK 900 RELATED ID: 1JGE RELATED DB: PDB REMARK 900 HLA-B*2705 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1JNJ RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF THE HUMAN BETA2- MICROGLOBULIN REMARK 900 RELATED ID: 1JHT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ANONAMERIC ALTERED REMARK 900 PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A. REMARK 900 RELATED ID: 1QLF RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G REMARK 900 RELATED ID: 1QQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER REMARK 900 CELL INHIBITORY RECEPTOR REMARK 900 RELATED ID: 1QR1 RELATED DB: PDB REMARK 900 POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A REMARK 900 LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE REMARK 900 RELATED ID: 1QRN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO REMARK 900 ALTERED HTLV-1 TAX PEPTIDE P6A REMARK 900 RELATED ID: 1QSE RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN A6-TCR BOUND TO HLA- A2 COMPLEXED WITH ALTERED REMARK 900 HTLV-1 TAX PEPTIDE V7R REMARK 900 RELATED ID: 1QSF RELATED DB: PDB REMARK 900 STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 REMARK 900 TAX PEPTIDE Y8A REMARK 900 RELATED ID: 1K5N RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1KPR RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1KTL RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1LDS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2 -MICROGLOBULIN REMARK 900 RELATED ID: 1OF2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408) REMARK 900 RELATED ID: 1FYT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELLRECEPTOR, REMARK 900 INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS IIMOLECULE, HLA-DR1 REMARK 900 RELATED ID: 1KGC RELATED DB: PDB REMARK 900 IMMUNE RECEPTOR REMARK 900 RELATED ID: 1TMC RELATED DB: PDB REMARK 900 TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-AW68 REMARK 900 COMPLEXED WITH A DECAMERIC PEPTIDE (EVAPPEYHRK) REMARK 900 RELATED ID: 2CLR RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEXED REMARK 900 WITH A DECAMERIC PEPTIDE FROM CALRETICULIN REMARK 900 RELATED ID: 2HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW 68.1 (HLA-AW 68.1, REMARK 900 HUMAN LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 3HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2. 1 (HLA-A2.1 HUMAN REMARK 900 LEUCOCYTE ANTIGEN) DBREF 1OGA A 1 276 UNP P01892 1A02_HUMAN 25 300 DBREF 1OGA B 0 0 PDB 1OGA 1OGA 0 0 DBREF 1OGA B 1 99 UNP P01884 B2MG_HUMAN 21 119 DBREF 1OGA C 1 9 PDB 1OGA 1OGA 1 9 DBREF 1OGA D 2 216 PDB 1OGA 1OGA 2 216 DBREF 1OGA E 1 114 PDB 1OGA 1OGA 1 114 DBREF 1OGA E 115 244 UNP P01850 TCB_HUMAN 1 130 DBREF 1OGA E 245 252 PDB 1OGA 1OGA 245 252 SEQADV 1OGA LYS E 118 UNP P01850 ASN 4 CONFLICT SEQADV 1OGA ASN E 119 UNP P01850 LYS 5 CONFLICT SEQADV 1OGA TYR E 151 UNP P01850 PHE 37 CONFLICT SEQADV 1OGA SER E 189 UNP P01850 CYS 75 CONFLICT SEQRES 1 A 276 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 A 276 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 276 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 276 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 276 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 A 276 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 A 276 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 276 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 276 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 A 276 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 A 276 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 A 276 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 A 276 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 A 276 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 276 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 A 276 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 A 276 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 276 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 276 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 276 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 276 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 276 TRP GLU PRO SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 GLY ILE LEU GLY PHE VAL PHE THR LEU SEQRES 1 D 215 MET GLN LEU LEU GLU GLN SER PRO GLN PHE LEU SER ILE SEQRES 2 D 215 GLN GLU GLY GLU ASN LEU THR VAL TYR CYS ASN SER SER SEQRES 3 D 215 SER VAL PHE SER SER LEU GLN TRP TYR ARG GLN GLU PRO SEQRES 4 D 215 GLY GLU GLY PRO VAL LEU LEU VAL THR VAL VAL THR GLY SEQRES 5 D 215 GLY GLU VAL LYS LYS LEU LYS ARG LEU THR PHE GLN PHE SEQRES 6 D 215 GLY ASP ALA ARG LYS ASP SER SER LEU HIS ILE THR ALA SEQRES 7 D 215 ALA GLN PRO GLY ASP THR GLY LEU TYR LEU CYS ALA GLY SEQRES 8 D 215 ALA GLY SER GLN GLY ASN LEU ILE PHE GLY LYS GLY THR SEQRES 9 D 215 LYS LEU SER VAL LYS PRO ASN ILE GLN ASN PRO ASP PRO SEQRES 10 D 215 ALA VAL TYR GLN LEU ARG ASP SER LYS SER SER ASP LYS SEQRES 11 D 215 SER VAL CYS LEU PHE THR ASP PHE ASP SER GLN THR ASN SEQRES 12 D 215 VAL SER GLN SER LYS ASP SER ASP VAL TYR ILE THR ASP SEQRES 13 D 215 LYS THR VAL LEU ASP MET ARG SER MET ASP PHE LYS SER SEQRES 14 D 215 ASN SER ALA VAL ALA TRP SER ASN LYS SER ASP PHE ALA SEQRES 15 D 215 CYS ALA ASN ALA PHE ASN ASN SER ILE ILE PRO GLU ASP SEQRES 16 D 215 THR PHE PHE PRO SER PRO GLU ASN ASP GLY GLY GLY CYS SEQRES 17 D 215 LYS HIS HIS HIS HIS HIS HIS SEQRES 1 E 252 MET VAL ASP GLY GLY ILE THR GLN SER PRO LYS TYR LEU SEQRES 2 E 252 PHE ARG LYS GLU GLY GLN ASN VAL THR LEU SER CYS GLU SEQRES 3 E 252 GLN ASN LEU ASN HIS ASP ALA MET TYR TRP TYR ARG GLN SEQRES 4 E 252 ASP PRO GLY GLN GLY LEU ARG LEU ILE TYR TYR SER GLN SEQRES 5 E 252 ILE VAL ASN ASP PHE GLN LYS GLY ASP ILE ALA GLU GLY SEQRES 6 E 252 TYR SER VAL SER ARG GLU LYS LYS GLU SER PHE PRO LEU SEQRES 7 E 252 THR VAL THR SER ALA GLN LYS ASN PRO THR ALA PHE TYR SEQRES 8 E 252 LEU CYS ALA SER SER SER ARG SER SER TYR GLU GLN TYR SEQRES 9 E 252 PHE GLY PRO GLY THR ARG LEU THR VAL THR GLU ASP LEU SEQRES 10 E 252 LYS ASN VAL PHE PRO PRO GLU VAL ALA VAL PHE GLU PRO SEQRES 11 E 252 SER GLU ALA GLU ILE SER HIS THR GLN LYS ALA THR LEU SEQRES 12 E 252 VAL CYS LEU ALA THR GLY PHE TYR PRO ASP HIS VAL GLU SEQRES 13 E 252 LEU SER TRP TRP VAL ASN GLY LYS GLU VAL HIS SER GLY SEQRES 14 E 252 VAL SER THR ASP PRO GLN PRO LEU LYS GLU GLN PRO ALA SEQRES 15 E 252 LEU ASN ASP SER ARG TYR SER LEU SER SER ARG LEU ARG SEQRES 16 E 252 VAL SER ALA THR PHE TRP GLN ASN PRO ARG ASN HIS PHE SEQRES 17 E 252 ARG CYS GLN VAL GLN PHE TYR GLY LEU SER GLU ASN ASP SEQRES 18 E 252 GLU TRP THR GLN ASP ARG ALA LYS PRO VAL THR GLN ILE SEQRES 19 E 252 VAL SER ALA GLU ALA TRP GLY ARG ALA ASP GLN ASP ARG SEQRES 20 E 252 GLY GLY GLY CYS ASP FORMUL 6 HOH *568(H2 O) HELIX 1 1 ALA A 49 GLU A 53 5 5 HELIX 2 2 GLY A 56 TYR A 85 1 30 HELIX 3 3 ASP A 137 ALA A 150 1 14 HELIX 4 4 HIS A 151 GLY A 162 1 12 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 GLN A 180 1 6 HELIX 7 7 GLN A 253 GLN A 255 5 3 HELIX 8 8 GLN D 81 THR D 85 5 5 HELIX 9 9 ARG D 164 ASP D 167 5 4 HELIX 10 10 ASP E 116 VAL E 120 5 5 HELIX 11 11 SER E 131 GLN E 139 1 9 HELIX 12 12 ALA E 198 GLN E 202 1 5 SHEET 1 AA 8 GLU A 46 PRO A 47 0 SHEET 2 AA 8 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46 SHEET 3 AA 8 ARG A 21 VAL A 28 -1 O ALA A 24 N PHE A 36 SHEET 4 AA 8 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27 SHEET 5 AA 8 THR A 94 VAL A 103 -1 O VAL A 95 N SER A 11 SHEET 6 AA 8 PHE A 109 TYR A 118 -1 N LEU A 110 O ASP A 102 SHEET 7 AA 8 LYS A 121 LEU A 126 -1 O LYS A 121 N TYR A 118 SHEET 8 AA 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AB 4 LYS A 186 ALA A 193 0 SHEET 2 AB 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AB 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AB 4 THR A 228 LEU A 230 -1 O GLU A 229 N ALA A 246 SHEET 1 AC 4 LYS A 186 ALA A 193 0 SHEET 2 AC 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AC 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AC 4 ARG A 234 PRO A 235 -1 O ARG A 234 N GLN A 242 SHEET 1 AD 3 THR A 214 ARG A 219 0 SHEET 2 AD 3 TYR A 257 GLN A 262 -1 O THR A 258 N GLN A 218 SHEET 3 AD 3 LEU A 270 ARG A 273 -1 O LEU A 270 N VAL A 261 SHEET 1 BA 4 LYS B 6 SER B 11 0 SHEET 2 BA 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BA 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 BA 4 GLU B 50 HIS B 51 -1 O GLU B 50 N TYR B 67 SHEET 1 BB 4 LYS B 6 SER B 11 0 SHEET 2 BB 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BB 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 BB 4 SER B 55 PHE B 56 -1 O SER B 55 N TYR B 63 SHEET 1 BC 4 GLU B 44 ARG B 45 0 SHEET 2 BC 4 GLU B 36 LYS B 41 -1 O LYS B 41 N GLU B 44 SHEET 3 BC 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 BC 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 DA 5 GLU D 6 SER D 8 0 SHEET 2 DA 5 LEU D 20 ASN D 25 -1 O TYR D 23 N SER D 8 SHEET 3 DA 5 ASP D 72 ILE D 77 -1 O SER D 73 N CYS D 24 SHEET 4 DA 5 LEU D 62 PHE D 66 -1 O THR D 63 N HIS D 76 SHEET 5 DA 5 VAL D 56 LEU D 59 -1 O LYS D 57 N PHE D 64 SHEET 1 DB 5 PHE D 11 GLN D 15 0 SHEET 2 DB 5 THR D 105 LYS D 110 1 O LYS D 106 N LEU D 12 SHEET 3 DB 5 GLY D 86 ALA D 93 -1 O GLY D 86 N LEU D 107 SHEET 4 DB 5 LEU D 33 GLN D 38 -1 O GLN D 34 N ALA D 91 SHEET 5 DB 5 VAL D 45 VAL D 50 -1 O VAL D 45 N ARG D 37 SHEET 1 DC 4 PHE D 11 GLN D 15 0 SHEET 2 DC 4 THR D 105 LYS D 110 1 O LYS D 106 N LEU D 12 SHEET 3 DC 4 GLY D 86 ALA D 93 -1 O GLY D 86 N LEU D 107 SHEET 4 DC 4 LEU D 99 PHE D 101 -1 O ILE D 100 N GLY D 92 SHEET 1 DD 7 ALA D 119 ARG D 124 0 SHEET 2 DD 7 SER D 132 THR D 137 -1 O VAL D 133 N LEU D 123 SHEET 3 DD 7 PHE D 168 SER D 177 -1 O ALA D 173 N PHE D 136 SHEET 4 DD 7 VAL D 153 ILE D 155 -1 O TYR D 154 N TRP D 176 SHEET 5 DD 7 PHE D 168 SER D 177 -1 O TRP D 176 N TYR D 154 SHEET 6 DD 7 THR D 159 MET D 163 -1 O THR D 159 N SER D 172 SHEET 7 DD 7 PHE D 168 SER D 177 -1 O PHE D 168 N MET D 163 SHEET 1 EA 2 ILE E 6 THR E 7 0 SHEET 2 EA 2 GLU E 26 GLN E 27 -1 O GLU E 26 N THR E 7 SHEET 1 EB 9 TYR E 12 LYS E 16 0 SHEET 2 EB 9 THR E 109 THR E 114 1 O ARG E 110 N LEU E 13 SHEET 3 EB 9 ALA E 89 SER E 96 -1 O ALA E 89 N LEU E 111 SHEET 4 EB 9 GLN E 58 LYS E 59 0 SHEET 5 EB 9 LEU E 45 SER E 51 -1 O TYR E 50 N GLN E 58 SHEET 6 EB 9 ALA E 33 GLN E 39 -1 O MET E 34 N SER E 51 SHEET 7 EB 9 ALA E 89 SER E 96 -1 O PHE E 90 N GLN E 39 SHEET 8 EB 9 TYR E 104 PHE E 105 -1 O TYR E 104 N SER E 95 SHEET 9 EB 9 ALA E 89 SER E 96 -1 O SER E 95 N TYR E 104 SHEET 1 EC 3 VAL E 21 LEU E 23 0 SHEET 2 EC 3 LEU E 78 VAL E 80 -1 O LEU E 78 N LEU E 23 SHEET 3 EC 3 TYR E 66 VAL E 68 -1 O SER E 67 N THR E 79 SHEET 1 ED 7 GLU E 124 PHE E 128 0 SHEET 2 ED 7 LYS E 140 PHE E 150 -1 O VAL E 144 N PHE E 128 SHEET 3 ED 7 TYR E 188 SER E 197 -1 O TYR E 188 N PHE E 150 SHEET 4 ED 7 VAL E 170 THR E 172 -1 O SER E 171 N ARG E 193 SHEET 5 ED 7 TYR E 188 SER E 197 -1 O ARG E 193 N SER E 171 SHEET 6 ED 7 LEU E 177 LYS E 178 -1 O LEU E 177 N SER E 189 SHEET 7 ED 7 TYR E 188 SER E 197 -1 O SER E 189 N LEU E 177 SHEET 1 EE 4 LYS E 164 VAL E 166 0 SHEET 2 EE 4 VAL E 155 VAL E 161 -1 O TRP E 159 N VAL E 166 SHEET 3 EE 4 HIS E 207 PHE E 214 -1 O ARG E 209 N TRP E 160 SHEET 4 EE 4 GLN E 233 TRP E 240 -1 O GLN E 233 N PHE E 214 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.09 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.03 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.06 SSBOND 4 CYS D 24 CYS D 90 1555 1555 2.06 SSBOND 5 CYS D 134 CYS D 184 1555 1555 2.03 SSBOND 6 CYS E 25 CYS E 93 1555 1555 2.02 SSBOND 7 CYS E 145 CYS E 210 1555 1555 2.03 CISPEP 1 TYR A 209 PRO A 210 0 -0.27 CISPEP 2 HIS B 31 PRO B 32 0 0.49 CISPEP 3 SER D 8 PRO D 9 0 -0.80 CISPEP 4 SER E 9 PRO E 10 0 -0.04 CISPEP 5 TYR E 151 PRO E 152 0 0.04 CRYST1 67.019 108.838 77.741 90.00 112.46 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014921 0.000000 0.006168 0.00000 SCALE2 0.000000 0.009188 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013919 0.00000